Atticus to present at AusBioInvest meeting in Melbourne on October 29 2024

Melbourne,30 September 2024 – Atticus Medical Pty Ltd, a leader in the development of pharmaceuticals with a focus on social impact, is pleased to announce its upcoming presentation at AusBioInvest 2024. This event will take place on October 29^th at the Park Hyatt Hotel in Melbourne, bringing together key stakeholders, investors, and industry leaders to discuss the latest advancements and investment opportunities in biotechnology.

Dr.John Lambert, General Manager of Atticus Medical, will present the company’s recent developments and strategic initiatives aimed at addressing critical healthcare challenges. The presentation will highlight Atticus Medical's research, recent milestones, and future plans for building its portfolio of socially impactful pharmaceutical products.

“We are excited to share our vision and progress with investors and industry peers at AusBioInvest 2024,” said Dr. Lambert. “Our commitment to combining scientific excellence with social responsibility positions us uniquely in the biotech industry, and we look forward to discussing our breakthroughs and investment potential with current and prospective shareholders.”

Atticus Medical invites investors and interested parties to join us at AusBioInvest 2024 and learn more about our mission to create pharmaceuticals with a social impact.

About Atticus Medical Pty Ltd

Atticus Medical is dedicated to developing innovative pharmaceutical solutions that address unmet medical needs while ensuring social responsibility. With a strong emphasis on research and development, Atticus Medical aims to make a positive impact on global health through its cutting-edge therapies and commitment to affordable healthcare.

For more information about the event and to register, please contact us.